Hong Kong Shares Inch Up After China Holds Benchmark Rates Steady; Qyuns Therapeutics Falls 9% on Debut
Hong Kong Shares Inch Up After China Holds Benchmark Rates Steady; Qyuns Therapeutics Falls 9% on Debut
Hong Kong shares finished fractionally higher on Wednesday on encouraging corporate results, with traders keeping a watchful eye on the future direction of the People's Bank of China's monetary policy.
由於企業業績令人鼓舞，香港股市週三收盤小幅上漲，交易員們密切關注中國人民銀行貨幣政策的未來方向。
The Hang Seng Index climbed 0.08%, or 13.59 points, to finish the day's trade at 16,543.07. The Hang Seng China Enterprises Index (HSCEI) rose 0.41%, or 23.78 points, to 5,803.99.
恒生指數上漲0.08％，漲幅13.59點，收於16,543.07點。恒生中國企業指數（HSCEI）上漲0.41％，或23.78點，至5,803.99點。
Chinese banks have kept the one-year and five-year loan prime rates unchanged on Wednesday at 3.45% and 3.95%, respectively. It follows the central bank's decision to keep the one-year, medium-term lending rate at 2%. PBoC Governor Pan Gongsheng has said the nation has "ample monetary policy space" and a "deep toolbox" to accomplish its goals.
中國銀行週三將一年期和五年期貸款最優惠利率分別維持在3.45％和3.95％不變。在此之前，央行決定將一年期中期貸款利率維持在2％。中國人民銀行行長潘功勝曾表示，該國有 “充足的貨幣政策空間” 和 “深度工具箱” 來實現其目標。
In corporate news, China Unicom Hong Kong (HKG:0762) advanced some 2% after the telco posted a record income for 2023.
在企業新聞方面，中國聯通香港（HKG: 0762）上漲了約2％，此前該電信公司公佈了2023年創紀錄的收入。
Li Ning (HKG:2331) gained about 6% after the homegrown sportswear maker reported higher revenue for 2023.
李寧（HKG: 2331）上漲約6％，此前這家本土運動服制造商報告2023年收入增加。
Meanwhile, drugmaker Qyuns Therapeutics (HKG:2509) lost over 9% on its market debut.
同時，製藥商Qyuns Therapeutics（HKG: 2509）在首次上市時下跌了9％以上。